-
Exploring the Impact of Dupilimab on the Patient Care Pathways: GHG Emissions of Patients With Moderate-to-Severe COPD In France
Sep 9, 2025, 16:22 PM -
Economic Burden and Healthcare Resource Utilization of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Germany: A Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of WIC Eligibility Extension in Preventing Maternal Postpartum Depression: US Payers’ Perspective
Sep 9, 2025, 16:22 PM -
Optimizing a New Patient-Reported Outcome Instrument for Proliferative Diabetic Retinopathy: A Psychometric Study
Sep 9, 2025, 16:22 PM -
Screening and Diagnosis of Paroxysmal Nocturnal Hemoglobinuria in Greece: Consensus Recommendations From a Multispecialty Expert Panel
Sep 9, 2025, 16:22 PM -
Enhancing Patient Experience of Subcutaneous Administration in Oncology: Development of a Dedicated Patient-Reported Experience Measure (PREM) Questionnaire Based on a Structured and Collaborative Approach
Sep 9, 2025, 16:22 PM -
The Economic Burden of Parkinson's Disease in the Netherlands: From Societal Impact to Investments in Health Solutions
Sep 9, 2025, 16:22 PM -
Economic Impact of Incorporating a Fecal Bacterial Signature to Optimize FIT-Based Colorectal Cancer Screening in Spain
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of RefluxStop for Treatment of Chronic Gastro-esophageal Reflux Disease: A US Medicare Perspective
Sep 9, 2025, 16:22 PM -
Defining Patient-Centered Outcomes in CAR-T-cell Therapy: Is There a Need for a Patient-Informed CAR-T PROM?
Sep 9, 2025, 16:22 PM -
Economic Evaluation in Alzheimer’s Disease: A Systematic Review
Sep 9, 2025, 16:22 PM -
Development of an AI-Powered Tool to Accelerate and Enhance Systematic Literature Reviews for Evidence-Based Decision Making in Clinical Research
Sep 9, 2025, 16:22 PM -
Fostamatinib-Induced Hepatomegaly: A Novel Signal Identified Through US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Sep 9, 2025, 16:22 PM -
Pulmonary Nodule (PN)-Related and Lung Cancer-Related Workup Costs Within the Two-Year Period After Diagnosis of a PN in the United States
Sep 9, 2025, 16:22 PM -
Requirements for Payer Recognition of Disease-Modifying Effect in New Drug Launches
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Inclisiran for the Management of Patients With Atherosclerotic Cardiovascular Disease in India: A Multipayer Analysis
Sep 9, 2025, 16:22 PM -
Use of AI in Breast Cancer Screening in England Has a Minimal Impact on Greenhouse Gas Emissions and May Increase Diagnostic Accuracy
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of Ustekinumab Against Vedolizumab Among Inflammatory Bowel Disease Patients With Extra-intestinal Manifestations in Egypt
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Artificial Intelligence Interventions for Musculoskeletal Disorders: Systematic Review
Sep 9, 2025, 16:22 PM -
Genomic Testing for Early Breast Cancer: Assessing the Value of Next-Generation Sequencing
Sep 9, 2025, 16:22 PM
